Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 19123 Cream vs Dovonex in Psoriasis Vulgaris
NCT00764751Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Sep 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LEO80122 in Psoriasis vulgaris (PV), sponsored by LEO Pharma. Started Sep 2008; status: completed.
02
Drugs
LEO80122
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT00764751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00764751.